✦ LIBER ✦

519 Entecavir is superior to lamivudine for the treatment of chronic hepatitis B (CHB): Results of a phase 3 Chinese study (ETV-023) in nucleoside-naïve patients

✍ Scribed by G. Yao; C. Chen; W. Lu; H. Ren; D. Tan; Y. Wang; D. Xu; M. Jiang; J. Liu; L. MacDonald; G. Yao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.110 Entecavir is well tolerated for th

✍ M. Raptopoulou Gigi; M. Manns; E. Cooney; R. Hindes; A. Cross; R. Wilber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A randomised double-blind phase II study

✍ J.J.Y. Sung; J.Y. Lai; S. Zeuzem; W.C. Chow; E. Heathcote; R. Perrillo; C. Brosg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Efficacy and safety of entecavir compare

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 223 KB

Efficacy and safety of entecavir compare

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 89 KB